According to a release, Rocket Lab USA announced on Tuesday that they signed a multi-launch agreement for their new ...

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

The Institute of Cost and Management Accountants of Bangladesh (ICMAB) on Thursday honoured 46 organisations in 17 categories for demonstrating excellence in corporate practices, evaluated on both ...

The United States government stands as the largest employer in the nation. Here are 10 public sector jobs within federal ...

UAB’s entry into AAC reignited the rivalry and the teams faced each other for the first time in 11 years at Protective ...

The U.S. Treasury Department said on Thursday that New York-based insurer MetLife's unit, American Life Insurance Company, ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

It attributed the downturn to the July-August mass upsurge, labour unrest, and prolonged flooding, which significantly impacted operations and distribution channels.

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...